Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Acta Diabetologica
Published in: Acta Diabetologica 1/2010

01-03-2010 | Original Article

The geospatial relation between UV solar radiation and type 1 diabetes in Newfoundland

Authors: Scott Sloka, Marie Grant, Leigh Anne Newhook

Published in: Acta Diabetologica | Issue 1/2010

Login to get access

Abstract

Type 1 diabetes (T1DM) has been previously associated with northern latitude and vitamin D insufficiency. This study investigates the geospatial association between average daily ultraviolet B (UVB) irradiance and T1DM across the province of Newfoundland (NL), Canada. NL has one of the highest documented incidences of T1DM worldwide. A complete list of patients diagnosed (1987–2005) with T1DM in the province of Newfoundland and Labrador (NL) was constructed using multiple sources. All places of habitation at diagnosis were ascertained. Ecological analysis using Bayesian estimation was performed employing both NASA UVB data and latitude. Correlation of T1DM to both UVB irradiation and latitude was measured. A statistically significant correlation of erythemal UVB irradiance was observed (−0.0284: 95% CI −0.0542 to −0.0096). A more significant correlation of T1DM was observed with erythemal UVB irradiance than with latitude. This study suggests that erythemal UVB radiation may be geospatially associated with the incidence of T1DM in NL.
Literature
1.
Franoin RK (1997) Diabetes mellitus. Pediatr Rev 18:383–392
2.
Gillespie KM (2006) Type 1 diabetes: pathogenesis and prevention. CMAJ 175(2):165–170PubMed
3.
Rahman P, Jones A, Curtis J, Bartlett S, Peddle L, Fernandez BA et al (2003) The Newfoundland population: a unique resource for genetic investigation of complex diseases. Hum Mol Genet 12(Spec No 2):R167–R172CrossRefPubMed
4.
Mannion JJ (1977) The peopling of Newfoundland: essays in historic geography. Memorial University of Newfoundland, St John’s
5.
6.
Tuomilehto J, Karvonen M, Pitkaniemi J, Virtala E, Kohtamaki K, Toivanen L et al (1999) Record-high incidence of Type I (insulin-dependent) diabetes mellitus in Finnish children. The Finnish childhood Type I diabetes registry group. Diabetologia 42(6):655–660CrossRefPubMed
7.
Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehto J (2000) Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 23(10):1516–1526CrossRefPubMed
8.
Newhook LA, Grant M, Sloka S, Hoque M, Paterson AD, Hagerty D et al (2008) Very high and increasing incidence of type 1 diabetes mellitus in Newfoundland and Labrador, Canada. Pediatr Diabetes 9(3 Pt 2):62–68CrossRefPubMed
9.
Onkamo P, Vaananen S, Karvonen M, Tuomilehto J (1999) Worldwide increase in incidence of type 1 diabetes: the analysis of the data on published incidence trends. Diabetologia 42:1395–1403CrossRefPubMed
10.
Karvonen M, Tuomilehto J, Libman I, LaPorte R (1993) A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus World Health Organization Diamond Project Group. Diabetologia 36(10):883–892CrossRefPubMed
11.
Diabetes Epidemiology Research International Group (1988) Geographic patterns of childhood insulin-dependent diabetes mellitus. Diabetes 37(8):1113–1119CrossRef
12.
Yang Z, Wang K, Li T, Sun W, Li Y, Chang YF et al (1998) Childhood diabetes in China enormous variation by place and ethnic group. Diabetes Care 21(4):525–529CrossRefPubMed
13.
Staples JA, Ponsonby AL, Lim LL, McMichael AJ (2003) Ecologic analysis of some immune-related disorders, including type 1 diabetes, in Australia: latitude, regional ultraviolet radiation, and disease prevalence. Environ Health Perspect 111(4):518–523PubMed
14.
Webb AR, Holick MF (1988) The role of sunlight in the cutaneous production of vitamin D3. Annu Rev Nutr 8:375–399CrossRefPubMed
15.
Webb AR, Kline L, Holick MF (1988) Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 67(2):373–378CrossRefPubMed
16.
Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM (2001) Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358(9292):1500–1503CrossRefPubMed
17.
The EURODIAB Substudy 2 Study Group (1999) Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. Diabetologia 42(1):51–54CrossRef
18.
Stene LC, Ulriksen J, Magnus P, Joner G (2000) Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring. Diabetologia 43(9):1093–1098CrossRefPubMed
19.
Sloka S, Grant M, Newhook LA (2008) Time series analysis of ultraviolet B radiation and type 1 diabetes in Newfoundland. Pediatr Diabetes 9(2):81–86CrossRefPubMed
20.
LaPorte R, McCarty D, Bruno G, Tajima N, Baba S (1993) Counting diabetes in the next millennium. Application of capture–recapture technology. Diabetes Care 16(2):528–534CrossRefPubMed
21.
NL Statistics Agency GoN (2003) Newfoundland and Labrador Statistics Agency. Provincial Government of NL
22.
Bear JC, Nemec TF, Kennedy JC, Marshall WH, Power AA, Kolonel VM et al (1987) Persistent genetic isolation in outport Newfoundland. Am J Med Genet 27(4):807–830CrossRefPubMed
23.
Martin LJ, Crawford MH, Koertvelyessy T, Keeping D, Collins M, Huntsman R (2000) The population structure of ten Newfoundland outports. Hum Biol 72(6):997–1016PubMed
24.
Mollie A, Richardson S (1991) Empirical Bayes estimates of cancer mortality rates using spatial models. Stat Med 10(1):95–112CrossRefPubMed
25.
Besag J (1974) Spatial interaction and the statistical analysis of lattice system. J R Stat Soc B 36:192–236
26.
Gilks WR, Clayton DG, Spiegelhalter DJ (1993) Modelling complexity: applications of Gibbs sampling in medicine. J R Stat Soc B 55:39–102
27.
Bernardinelli L, Montomoli C (1992) Empirical Bayes versus fully Bayesian analysis of geographical variation in disease risk. Stat Med 11(8):983–1007CrossRefPubMed
28.
Clayton D, Kaldor J (1987) Empirical Bayes estimates of age-standardized relative risks for use in disease mapping. Biometrics 43(3):671–681CrossRefPubMed
29.
Besag J, York J, Mollie A (1991) Bayesian image restoration with two applications in spatial statistics. Ann Inst Stat Math 43:1–59CrossRef
30.
Spiegelhalter DJ, Thomas A, Best NG, Gilks WR (1996) BUGS: Bayesian inference using Gibbs sampling, Version 0.5. Medical Research Council Biostatistics Unit, Cambridge
31.
Sloka JS, Pryse-Phillips WE, Stefanelli M (2008) The relation of ultraviolet radiation and multiple sclerosis in Newfoundland. Can J Neurol Sci 35(1):69–74PubMed
32.
Clayton DG, Bernardinelli L (1992) Bayesian methods for mapping disease risk. In: Elliott P, Cuzick J, English DR, Stern R (eds) Geographical and environmental epidemiology: methods for small-area studies. Oxford University Press, Oxford
33.
Sloka JS, Crowley M, Fernandez B, Maroun F (2006) Bayesian small area cluster analysis of neural tube defects in Newfoundland. Can J Public Health 97(5):393–397PubMed
34.
Richardson S, Monfort C, Green M, Draper G, Muirhead C (1995) Spatial variation of natural radiation and childhood leukaemia incidence in Great Britain. Stat Med 14(21–22):2487–2501CrossRefPubMed
35.
Bernardinelli L, Pascutto C, Montomoli C, Gilks W (2000) Investigating the genetic association between diabetes and malaria: an application of Bayesian ecological regression models with errors in covariates. In: Elliott P, Wakefield J, Best N, Briggs D (eds) Spatial epidemiolgy: methods and applications. Oxford University Press, Oxford, pp 286–301
36.
Bernardinelli L, Pascutto C, Montomoli C, Komakec J, Gilks W (1999) Ecological regression with errors in covariates. In: Lawson A, Boehning D, Lasaffree E, Biggeri A, Viel J, Bertolline R (eds) Disease mapping and risk assessment for public health. Wiley, Chichester, pp 329–348
37.
Tukiendorf A (2001) An ecological analysis of leukemia incidence around the highest 137Cs concentration in Poland. Cancer Causes Control 12(7):653–659CrossRefPubMed
38.
Cardwell CR, Carson DJ, Patterson CC (2006) Higher incidence of childhood-onset type 1 diabetes mellitus in remote areas: a UK regional small-area analysis. Diabetologia 49(9):2074–2077CrossRefPubMed
39.
Gale CR, Martyn CN (1995) Migrant studies in multiple sclerosis. Prog Neurobiol 47(4–5):425–448CrossRefPubMed
40.
Macpherson A, Macpherson J (2006) The natural environment of Newfoundland, past and present. Department of Geography, Memorial University of Newfoundland, St John’s
Metadata
Title
The geospatial relation between UV solar radiation and type 1 diabetes in Newfoundland
Authors
Scott Sloka
Marie Grant
Leigh Anne Newhook
Publication date
01-03-2010
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 1/2010
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-009-0100-0

Other articles of this Issue 1/2010

Acta Diabetologica 1/2010 Go to the issue

Review

Exercise for the management of type 2 diabetes: a review of the evidence

Short Communication

Association of homozygous SDF-1 3′A genotype with proliferative diabetic retinopathy

Original Article

Profile of patients with diabetes in Eritrea: results of first phase registry analyses

Review Article

Insulin-like growth factor binding protein: a possible marker for the metabolic syndrome?

Original Article

Epidemiology of type 1 diabetes among Silesian children aged 0–14 years, 1989–2005

Original Article

Microaneurysm number and distribution in the macula of Chinese type 2 diabetics with early diabetic retinopathy: a population-based study in Kinmen, Taiwan
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits